Abbreviations:IV (intravenous), ICD (International Classification of Diseases), MedDRA (Medical Dictionary for Regulatory Activities Terminology)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- Use of intravenous iron and risk of anaphylaxis: a multinational observational post-authorisation safety study in Europe.Pharmacoepidemiol Drug Saf. 2021; 30: 1447-1457
- Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-deficiency Anemia.JAMA. 2020; 323: 432-443
- Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia.Expert Rev Hematol. 2020; 13: 187-195
- Incidence and severity of anaphylactoid reactions to colloid volume substitutes.Lancet. 1977; 309: 466-469
- Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions.Br J Clin Pharmacol. 2017; 83: 1118-1125
- Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer®) versus ferric carboxy-maltose (Ferinject®). A single center, cohort study.Br J Clin Pharmacol. 2019; 85: 385-392
- Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review.Transfus Altern Transfus Med. 2007; 9: 8-36
- Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.Br J Pharmacol. 2015; 172: 5025-5036